BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)

NCT00586443 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Herbert Hurwitz, MD

Collaborators